| ISIN | US92189F6925 |
|---|---|
| TER | 0.00% |
| Replication | Synthetic |
| Distribution | Accumulating |
| Launch Year | 2011 |
| AUM | $0.59 billion |
| Provider | VanEck |
| Exchange | USA Stocks (USA) |
| Currency | USD |
| Country | USA |
| Type | ETF |
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Consult fund provider.
| Period | Return (%) |
|---|---|
| 1 Month | 1.70% |
| 3 Months | -4.99% |
| 6 Months | -1.65% |
| 1 Year | -3.89% |
| 3 Years | 20.86% |
| 5 Years | 53.85% |
| Since Inception | 319.40% |
Distribution: Accumulating
Volatility and risk metrics are calculated based on historical price movements.
This ETF is widely available on major European brokers like Trade Republic, Scalable, and DEGIRO.
Compare brokers →Exchange: USA Stocks (USA)
Currency: USD
Is this ETF accumulating?
Yes, it reinvests dividends.